PF3D7_0303900

PF3D7_0303900 (PfRKIP) is a phosphatidylethanolamine-binding protein (PEBP) family member of P. falciparum that functions as a lipid-responsive regulator of the essential kinase PfCDPK1 during asexual blood-stage schizogony (PMID:7637711, PMID:39842334). It is expressed throughout schizogony with peak abundance in late schizonts, and at physiological pH binds phosphatidic acid and phosphorylated phosphatidylinositol lipids such as PtdIns(3)P through a distinctive IKK motif and conserved PEBP-domain residues, as defined by mutagenesis that reduced PtdIns(3)P interaction (PMID:39842334). PfRKIP physically associates with PfCDPK1 in the parasite and inhibits its kinase activity; upon substrate engagement, PfCDPK1 hyper-phosphorylates PfRKIP, driving dissociation of the complex and permitting PfCDPK1 to trans-phosphorylate its downstream targets (PMID:39842334). The high-resolution crystal structure of the P. vivax ortholog shows the canonical PEBP fold augmented by a distinctive left-handed alpha-helical region beside the phospholipid-binding site, marking this protein as a structurally distinct PEBP subfamily (PMID:17329808). Beyond this lipid-binding and kinase-regulatory role, no further mechanistic detail for PF3D7_0303900 has been characterized in the available corpus.

1. 1995 Low

   Establishing the identity of an uncharacterized Plasmodium protein was the first step; sequencing placed PF3D7_0303900 in the PEBP family, framing all later functional hypotheses.

   Evidence Molecular cloning and primary amino acid sequence determination in P. falciparum

   PMID:7637711

   Open questions at the time

   • Sequence-based classification only, with no biochemical or functional validation
   • No lipid-binding, structural, or partner information at this stage
2. 2007 Medium

   Whether the PEBP assignment corresponded to a genuine fold, and whether the Plasmodium protein differed structurally from canonical PEBPs, was resolved by solving the ortholog structure.

   Evidence X-ray crystallography (MAD phasing, 1.3 Å) of the P. vivax ortholog

   PMID:17329808

   Open questions at the time

   • Structure determined in the P. vivax ortholog, not PF3D7_0303900 itself
   • No functional mutagenesis mapping the significance of the distinctive alpha-helical region
   • Structure alone did not identify ligands or binding partners
3. 2025 Medium

   The specific lipid ligand of the protein and the residues responsible were unknown; binding assays and mutagenesis defined phosphatidic acid and phosphoinositide recognition via the IKK motif and PEBP-domain residues, giving the protein a defined biochemical activity.

   Evidence pH-dependent lipid-binding assays, PEBP-domain mutagenesis, and in silico docking in P. falciparum

   PMID:39842334

   Open questions at the time

   • Single-lab study without independent replication
   • Physiological consequence of lipid binding within the parasite not established
   • Whether lipid binding modulates the PfCDPK1 interaction was not directly tested
4. 2025 Medium

   How this PEBP protein connects to parasite signaling was addressed by showing it binds and inhibits the essential kinase PfCDPK1, establishing a substrate-triggered phospho-switch regulatory role.

   Evidence ELISA, immunofluorescence co-localization, proximity biotinylation (BioID), kinase activity and phosphorylation/dissociation assays in P. falciparum

   PMID:39842334

   Open questions at the time

   • Single-lab study; interaction not confirmed by an independent group
   • Downstream PfCDPK1 substrates whose trans-phosphorylation is gated by PfRKIP were not identified
   • No genetic knockout/knockdown phenotype establishing the requirement of PfRKIP for parasite growth

• It remains unknown whether lipid binding and PfCDPK1 regulation are mechanistically coupled and what biological process this controls in the parasite.
• No genetic loss-of-function phenotype for PF3D7_0303900 reported
• Link between phosphoinositide/phosphatidic acid binding and PfCDPK1 inhibition not experimentally connected
• Cellular process (e.g. egress/invasion) regulated by the PfRKIP–PfCDPK1 switch not defined